Endra develops photoacoustic imaging technology for real-time visualization of blood flow and tissue composition in clinical settings.
$50MSeries A
a16z betting $50M on photoacoustic imaging signals they see real clinical adoption velocity in deep-tech medical devices—this isn't pure R&D anymore. At this check size, Endra is likely scaling manufacturing, building out regulatory pathways, and hiring commercial teams to land hospital contracts. If you're in adjacent medical imaging or diagnostic hardware, this validates that investors will fund the unglamorous work of getting novel physics into operating rooms, not just the science.